Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine CandidateBusiness Wire • 07/31/20
Pfizer Analysts See 'Surprisingly Strong' Vaccine Updates In Q2, Question Biopharma's Blockbuster PotentialBenzinga • 07/29/20
Pfizer To Charge $39 Per Coronavirus Vaccine Course To All Developed Countries For Similar Volume Commitments As USBenzinga • 07/29/20
Pfizer's (PFE) CEO Albert Bourla on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/28/20
Pfizer CEO says Trump's executive orders overhauling U.S. drug pricing will cause 'enormous destruction'CNBC • 07/28/20
Pfizer shares rise after it raises 2020 revenue outlook and reports better-than-expected earningsCNBC • 07/28/20
Pfizer Earnings Top, Coronavirus Vaccine Enters Phase 3 Trial; Dow Stock Nears Buy PointInvestors Business Daily • 07/28/20